Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

SPH KDL Health

    • Home
    • SPH KDL Health
Company Deals

Vazyme Biotech and SPH KDL Health Join Forces to Promote Alzheimer’s Blood Tests

Fineline Cube May 11, 2024

Vazyme Biotech Co., Ltd (SHA: 688105), a prominent biotech company based in China, has entered...

Recent updates

  • Daiichi Sankyo Secures Breakthrough Therapy Designation for CDH6‑Targeted ADC Raludotatug Deruxtecan in Ovarian Cancer
  • Novo Nordisk Expands Aspect Biosystems Partnership for Diabetes Cell Therapy
  • Sisram Medical Partners with Fosun Pharma Subsidiary on Local Production Base
  • BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto‑Injector
  • Syngene Extends BMS Partnership to 2035, Expanding CRDMO Services
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

Daiichi Sankyo Secures Breakthrough Therapy Designation for CDH6‑Targeted ADC Raludotatug Deruxtecan in Ovarian Cancer

Company Deals

Novo Nordisk Expands Aspect Biosystems Partnership for Diabetes Cell Therapy

Company Deals

Sisram Medical Partners with Fosun Pharma Subsidiary on Local Production Base

Company Deals

BD and Ypsomed Develop Neopak XtraFlow 5.5mL Prefilled Syringe for YpsoMate Auto‑Injector

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.